Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-UVB for Resistant Tinea
NCT07242703Not yet recruiting
- Sponsor
- Cairo University
- Start
- Dec 2025
- Primary completion
- Apr 2026
01
Overview
Randomised, open-label trial in tinea corporis and Tinea cruris (TC) (2 arms), sponsored by Cairo University. Primary endpoint: Dermatophytosis Severity Score at 8 weeks. Planned start Dec 2025; status: not yet recruiting.
02
Conditions
tinea corporisTinea cruris (TC)
Beyond the preview
Go deeper on NCT07242703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242703.